Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $4.90 and traded as low as $3.9850. Ampliphi Biosciences shares last traded at $4.07, with a volume of 307,471 shares trading hands.
Ampliphi Biosciences Stock Up 2.0%
The stock has a 50 day moving average price of $4.89 and a 200-day moving average price of $7.60.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation was a biotechnology company focused on developing bacteriophage-based therapeutics. Bacteriophages are viruses that selectively infect and destroy specific bacteria, and the company’s programs were aimed at addressing bacterial infections, including those caused by antibiotic-resistant pathogens.
Its development pipeline included AB-SA01, an investigational phage therapy targeting Staphylococcus aureus, and AB-PA01, designed to target Pseudomonas aeruginosa.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
